MetLife (MET) Reports Q1 Earnings: What Key Metrics Have to Say

01.05.25 02:00 Uhr

Werte in diesem Artikel
Aktien

65,95 EUR -1,18 EUR -1,76%

Indizes

PKT PKT

16.491,4 PKT 73,1 PKT 0,45%

2.694,7 PKT 1,9 PKT 0,07%

5.569,1 PKT 8,2 PKT 0,15%

MetLife (MET) reported $18.83 billion in revenue for the quarter ended March 2025, representing a year-over-year increase of 10.6%. EPS of $1.96 for the same period compares to $1.83 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $18.21 billion, representing a surprise of +3.40%. The company delivered an EPS surprise of -1.51%, with the consensus EPS estimate being $1.99.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.Here is how MetLife performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Total Adjusted Revenue- Latin America: $1.92 billion compared to the $1.95 billion average estimate based on three analysts. The reported number represents a change of +2% year over year. Adjusted Revenue- Corporate & other- Net investment income: $71 million compared to the $107.65 million average estimate based on three analysts. The reported number represents a change of -33% year over year. Total Adjusted Revenue- EMEA: $726 million versus $703.80 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +7.7% change. Total Adjusted Revenue- Asia: $2.89 billion compared to the $2.99 billion average estimate based on three analysts. The reported number represents a change of +1.2% year over year. Revenue- Premiums: $11.72 billion compared to the $10.97 billion average estimate based on five analysts. The reported number represents a change of +16.6% year over year. Revenue- Other Revenues: $687 million versus the five-analyst average estimate of $631.98 million. The reported number represents a year-over-year change of +1.9%. Revenue- Net investment income: $4.89 billion versus the five-analyst average estimate of $5.27 billion. The reported number represents a year-over-year change of -10.1%. Revenue- Universal life and investment-type product policy fees: $1.23 billion compared to the $1.27 billion average estimate based on five analysts. The reported number represents a change of -1.5% year over year. Adjusted Revenue- MetLife Holdings- Premiums: $657 million compared to the $671.62 million average estimate based on three analysts. The reported number represents a change of -7.9% year over year. Adjusted Revenue- MetLife Holdings- Universal life and investment- type product policy fees: $86 million versus $76.60 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +10.3% change. Adjusted Revenue- MetLife Holdings- Net investment income: $989 million compared to the $985.62 million average estimate based on three analysts. The reported number represents a change of -2.1% year over year. Adjusted Revenue- MetLife Holdings- Other Revenues: $37 million compared to the $40.15 million average estimate based on three analysts. The reported number represents a change of -26% year over year. View all Key Company Metrics for MetLife here>>>Shares of MetLife have returned -5.8% over the past month versus the Zacks S&P 500 composite's -0.2% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.Only $1 to See All Zacks' Buys and SellsWe're not kidding.Several years ago, we shocked our members by offering them 30-day access to all our picks for the total sum of only $1. No obligation to spend another cent.Thousands have taken advantage of this opportunity. Thousands did not - they thought there must be a catch. Yes, we do have a reason. We want you to get acquainted with our portfolio services like Surprise Trader, Stocks Under $10, Technology Innovators,and more, that closed 256 positions with double- and triple-digit gains in 2024 alone.See Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report MetLife, Inc. (MET): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: MetLife und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.

Ausgewählte Hebelprodukte auf MetLife

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf MetLife

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu MetLife Inc.

Wer­bung

Analysen zu MetLife Inc.

DatumRatingAnalyst
02.01.2018MetLife HoldDeutsche Bank AG
03.11.2017MetLife OutperformRBC Capital Markets
25.05.2017MetLife OutperformFBR & Co.
09.12.2016MetLife HoldStandpoint Research
28.11.2016MetLife Mkt PerformFBR & Co.
DatumRatingAnalyst
03.11.2017MetLife OutperformRBC Capital Markets
25.05.2017MetLife OutperformFBR & Co.
05.05.2016MetLife OutperformRBC Capital Markets
31.07.2015MetLife BuyDeutsche Bank AG
22.06.2015MetLife OutperformRBC Capital Markets
DatumRatingAnalyst
02.01.2018MetLife HoldDeutsche Bank AG
09.12.2016MetLife HoldStandpoint Research
28.11.2016MetLife Mkt PerformFBR & Co.
13.07.2016MetLife HoldDeutsche Bank AG
15.03.2016MetLife NeutralUBS AG
DatumRatingAnalyst
04.12.2006Update MetLife Inc.: UnderperformFriedman, Billings Ramsey & Co
14.09.2005MetLife DowngradeDeutsche Securities
14.09.2005Update MetLife Inc.: SellDeutsche Securities

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für MetLife Inc. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen